机译:耐舒尼替尼的胃肠道间质瘤在KIT基因的激活环中具有顺式突变
Department of Surgery Osaka University Graduate School of Medicine 2-2 Yamadaoka Suita Osaka 565-0871 Japan;
Department of Surgery Osaka University Graduate School of Medicine 2-2 Yamadaoka Suita Osaka 565-0871 Japan;
Department of Surgery Osaka University Graduate School of Medicine 2-2 Yamadaoka Suita Osaka 565-0871 Japan;
Division of Gastrointestinal Oncology/Digestive Endoscopy National Cancer Center Hospital East Chiba Japan;
Department of Medical Oncology National Cancer Center Hospital Tokyo Japan;
Department of Gastroenterology Hokkaido University Graduate School of Medicine Hokkaido Japan;
Department of Surgery Osaka University Graduate School of Medicine 2-2 Yamadaoka Suita Osaka 565-0871 Japan;
Department of Surgical Pathology Hyogo Medical College Kobe Japan;
Acquired resistance; KIT; Imatinib; Sunitinib; Mutation;
机译:耐舒尼替尼的胃肠道间质瘤在KIT基因的激活环中具有顺式突变。
机译:切除耐舒尼替尼的胃肠道间质瘤后迅速复发,该肿瘤在c-KIT基因第13外显子中具有继发突变
机译:伊马替尼在具有KIT激活环结构域突变(外显子17突变pN822K)的胃肠道间质瘤(GIST)中不活动
机译:通过增强螺旋CT扫描评价肿瘤血管密度的恶性肿瘤性质肿瘤
机译:胰岛素样生长因子结合蛋白3在胃肠道间质瘤中的作用。
机译:伊马替尼在具有KIT激活环结构域突变(外显子17突变pN822K)的胃肠道间质瘤(GIST)中不活跃
机译:C-kit和PDGFRα中的激活突变仅在胃肠道基质肿瘤中发现,而不是在其他肿瘤中过表达这些伊马替尼甲磺酸酯靶基因的肿瘤